Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Figure 2

Influence of adjuvant chemotherapy on overall survival after potentially curative resection of colorectal liver metastases in patients with a borderline risk status. A. Overall survival of patients with a MSKCC-CRS 2 stratified for the type of adjuvant therapy (p = 0.62). B. Overall survival of patients with a MSKCC-CRS 3 stratified for the type of adjuvant therapy (p = 0.01). Data are presented as Cox proportional hazards.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us